BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12442995)

  • 1. Potential exposures and risks from beryllium-containing products.
    Willis HH; Florig HK
    Risk Anal; 2002 Oct; 22(5):1019-33. PubMed ID: 12442995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
    Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
    J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review.
    McCleskey TM; Buchner V; Field RW; Scott BL
    Rev Environ Health; 2009; 24(2):75-115. PubMed ID: 19658317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
    Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
    Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of beryllium antibodies in risk assessment and health surveillance: two case studies.
    Clarke SM; Thurlow SM; Hilmas DE
    Toxicol Ind Health; 1995; 11(4):399-411. PubMed ID: 8748421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beryllium: a modern industrial hazard.
    Kreiss K; Day GA; Schuler CR
    Annu Rev Public Health; 2007; 28():259-77. PubMed ID: 17094767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 1: historical exposure reconstruction.
    Virji MA; Park JY; Stefaniak AB; Stanton ML; Day GA; Kent MS; Kreiss K; Schuler CR
    Scand J Work Environ Health; 2012 May; 38(3):247-58. PubMed ID: 21850365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beryllium "double standard" standard.
    Egilman DS; Bagley S; Biklen M; Golub AS; Bohme SR
    Int J Health Serv; 2003; 33(4):769-812. PubMed ID: 14758859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk.
    McCawley MA; Kent MS; Berakis MT
    Appl Occup Environ Hyg; 2001 May; 16(5):631-8. PubMed ID: 11370941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison and critique of historical and current exposure assessment methods for beryllium: implications for evaluating risk of chronic beryllium disease.
    Kolanz ME; Madl AK; Kelsh MA; Kent MS; Kalmes RM; Paustenbach DJ
    Appl Occup Environ Hyg; 2001 May; 16(5):593-614. PubMed ID: 11370938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 2: validation of historical exposures.
    Park JY; Virji MA; Stefaniak AB; Stanton ML; Day GA; Kent MS; Schuler CR; Kreiss K
    Scand J Work Environ Health; 2012 May; 38(3):259-69. PubMed ID: 21847507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating historical exposures of workers in a beryllium manufacturing plant.
    Sanderson WT; Petersen MR; Ward EM
    Am J Ind Med; 2001 Feb; 39(2):145-57. PubMed ID: 11170157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed.
    Henneberger PK; Goe SK; Miller WE; Doney B; Groce DW
    J Occup Environ Hyg; 2004 Oct; 1(10):648-59. PubMed ID: 15631056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure pathway assessment at a copper-beryllium alloy facility.
    Day GA; Dufresne A; Stefaniak AB; Schuler CR; Stanton ML; Miller WE; Kent MS; Deubner DC; Kreiss K; Hoover MD
    Ann Occup Hyg; 2007 Jan; 51(1):67-80. PubMed ID: 16844720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations for the development of health-based surface dust cleanup criteria for beryllium.
    Shay E; De Gandiaga E; Madl AK
    Crit Rev Toxicol; 2013 Mar; 43(3):220-43. PubMed ID: 23445217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction to beryllium: uses, regulatory history, and disease.
    Kolanz ME
    Appl Occup Environ Hyg; 2001 May; 16(5):559-67. PubMed ID: 11370935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic beryllium disease and cancer risk estimates with uncertainty for beryllium released to the air from the Rocky Flats Plant.
    McGavran PD; Rood AS; Till JE
    Environ Health Perspect; 1999 Sep; 107(9):731-44. PubMed ID: 10464074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of personal airborne exposures and surface contamination from x-ray vaporization of beryllium targets at the National Ignition Facility.
    Paik SY; Epperson PM; Kasper KM
    J Occup Environ Hyg; 2017 Jun; 14(6):438-447. PubMed ID: 28278063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant.
    Henneberger PK; Cumro D; Deubner DD; Kent MS; McCawley M; Kreiss K
    Int Arch Occup Environ Health; 2001 Apr; 74(3):167-76. PubMed ID: 11355290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beryllium in the environment: a review.
    Taylor TP; Ding M; Ehler DS; Foreman TM; Kaszuba JP; Sauer NN
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2003 Feb; 38(2):439-69. PubMed ID: 12638707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.